An Observational Study on Sarilumab-exposed Pregnancies

NCT03378219 · clinicaltrials.gov ↗

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis -Exposure During Pregnancy

Interventions

DRUG: Sarilumab SAR153191 (REGN88)

Sponsor

Sanofi

Collaborators

[object Object]